H2AX and glioblastoma: The findings presented in the current study also demonstrate a dose-dependent reduction in Ki67, Nop10, and H2AX expressions in tumor cells around blood vessels, alongside GFAP expression, following treatment with BA in astrocytes surrounding the tumors in rat GBM model.